Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy

NCT01893788 is registered in ClinicalTrials.gov with Nagoya University as lead sponsor.

NCT NCT01893788
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01893788 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eplerenone and Aliskiren Research Targeting Hypertensive Patients With Left Ventricular Hypertrophy
Lead sponsor
Nagoya University
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2013
Completion date
Not reported
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertensive left ventricular hypertrophy